Skip to content

Could interactions with other antiretrovirals cause ‘tenofovir-associated’ kidney disease?

South Africa: concern as MSF starts handover of HIV/AIDS treatment

Hepatitis C protease inhibitor does well in early clinical trial

Risk of altered blood fat levels varies according to ethnic background, study shows

Fatigue may be misdiagnosed as depression during anti-HCV therapy in HIV coinfected

Fat loss associated with Combivir but not Truvada

Unusual abacavir hypersensitivity reaction involving severe respiratory symptoms reported

Almost a third of Indian patients make changes to first-line treatment regimen because of side-effects or cost

Immune reconstitution syndrome risk highest in those commencing HIV therapy with advanced HIV disease